Track the ALMIRALL, S.A. share price and the full directors' dealings record of the company, a listed issuer based in Spain. Shares trade on the ES market, under the oversight of CNMV. Operating in the Health Care sector, ALMIRALL, S.A. has recorded 20 public disclosures. Market capitalisation: €2.4bn. The latest transaction was disclosed on 22 June 2023 (Purchase). Among the most active insiders: PAOLO CIONINI. Every trade is openly available.
20
Insider Decl.
n/a
Thresholds
€190,917
5 ops.
Buy Volume
€7m
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate ALMIRALL, S.A. Buy (bullish), based on 12 analysts. Average price target: €14.58.
30Σ signal
Buys €190,917€7m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,107 of 29,024 companies
52.8
score / 100
Value
47
Quality
59
FCF yld1.5%
Earn yld1.9%
EV/EBITDA11.8x
ROE4.0%
Gross mgn79%
Net mgn4.2%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
ALMIRALL, S.A. is a Spanish pharmaceutical company focused on developing dermatological and respiratory treatments. It is listed on the Spanish stock market XMAD.